COMPANIES COVERED
PfizerDownload FREE Report Sample
Download Free sampleImmune globulin?(Ig) short-term protection against hepatitis A and measles
Animal-derived Immune Globulin s Market contains market size and forecasts of Animal-derived Immune Globulin Products in global, including the following market information:
Global Animal-derived Immune Globulin Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Animal-derived Immune Globulin Products Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Animal-derived Immune Globulin Products companies in 2021 (%)
The global Animal-derived Immune Globulin Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IVIg Liquid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Instituto Bioclon, Merck & Co, Sanofi, Protherics and Genzyme Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Animal-derived Immune Globulin Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal-derived Immune Globulin Products Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Animal-derived Immune Globulin Products Market Segment Percentages, by Type, 2021 (%)
IVIg Liquid
IVIg Powder
Global Animal-derived Immune Globulin Products Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Animal-derived Immune Globulin Products Market Segment Percentages, by Application, 2021 (%)
Immunodeficiency
Autoimmune Disease
Acute Infection
Global Animal-derived Immune Globulin Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Animal-derived Immune Globulin Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal-derived Immune Globulin Products revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Animal-derived Immune Globulin Products revenues share in global market, 2021 (%)
Key companies Animal-derived Immune Globulin Products sales in global market, 2017-2022 (Estimated), (MT)
Key companies Animal-derived Immune Globulin Products sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
